James F. McDonough
Of Counsel
732-568-8360 jmcdonough@sh-law.comFirm Insights
Walgreens urged to undergo tax "inversion"
Author: James F. McDonough
Date: April 30, 2014
Key Contacts
Back
Walgreens, a staple U.S. drugstore, has been headquartered in Illinois for almost a century. The company got its start in downstate Dixon, Ill., before moving its corporate headquarters to Chicago and then eventually to Deerfield, Ill., according to the Chicago Tribune. The company’s next corporate move may take it further away – to Bern, Switzerland.
A group of influential shareholders, including Goldman Sachs Investment Partners and hedge funds Jana Partners, Corvex and Och-Ziff, are reportedly pressuring the company to undergo a so-called “inversion,” according to the Financial Times. This move would allow Walgreens to relocate to Switzerland, paying a dramatically lower corporate income tax rate. The corporate income tax in the U.S. is among the highest in the world – a factor that has prompted a number of companies in the public eye to redomicile their headquarters abroad.
Analysts at UBS found that Walgreens’ tax rate was anticipated to be 37.5 percent this year, according to the news source. This is considerably higher than the tax rate for Alliance Boots, a formerly UK-based pharmacy chain of which Walgreens recently acquired 45 percent. Boots is anticipated to pay a tax rate of only 20 percent as a result of having made such an inversion a few years ago.
UBS explained in a note last month that Walgreens could increase earnings per share by 75 percent by undergoing an inversion, the news source explained. The finance group noted, however, that “Walgreens’ management seems more hesitant to pull the trigger near-term due to perceived political risks.”
Many think that Walgreens is right to be concerned about political risk, particularly because of recent attention paid to corporate tax in the U.S. and the face-to-face nature of the company’s interactions with the public. Inversions have become very popular in the last two years, FT explained, especially in the pharmaceutical sector.
- Practices: Tax and Trusts & Estates
- Locations: Red Bank, NJ, New York City, Little Falls, NJ
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Related Posts
See all
One Big Beautiful Bill: New Tip Income Tax Rules Employers & Workers Need to Know
Part 2 – Tips Excluded from Income Certain employees and independent contractors may be eligible to deduct tips from their income for tax years 2025 through 2028 under provisions included in the One Big Beautiful Bill. The deduction is capped at $25,000 per year and begins to phase out at $150,000 of modified adjusted gross […]
Author: Scott H. Novak
One Big Beautiful Bill: New Overtime Tax Rules Employers and Employees Need to Know
Part 1 – Overtime Pay and Income Tax Treatment Overview This Firm Insights post summarizes one provision of the “One Big Beautiful Bill” related to the tax treatment of overtime compensation and related employer wage reporting obligations. Overtime Pay and Employee Tax Treatment The Fair Labor Standards Act (FLSA) generally requires that overtime be paid […]
Author: Scott H. Novak
New York’s FAIR Business Practices Act: What the New Consumer Protection Measure Means for Your Business
In 2025, New York enacted one of the most consequential updates to its consumer protection framework in decades. The Fostering Affordability and Integrity through Reasonable Business Practices Act (FAIR Act) significantly expands the scope and strength of New York’s long-standing consumer protection statute, General Business Law § 349, and alters the compliance landscape for New York […]
Author: Dan Brecher
How to Reduce Legal Risk as Your New Jersey Business Grows in 2026
For many New Jersey businesses, growth is a primary objective for the New Year. However, it is important to recognize that growth involves both opportunity and risk. For example, business expansion often results in complex contracts, an increased workforce, new regulatory requirements, and heightened exposure to disputes. Without proactive planning, even routine growth can lead […]
Author: Ken Hollenbeck
Crypto Investor Protection: SEC and CFTC Enforcement Trends
Crypto investor protection continues to evolve, with the SEC and CFTC investing resources and coordinating more closely to uphold regulatory standards. Whether you’re a retail investor, an institutional trader, or part of a crypto startup, understanding enforcement trends is essential for navigating this dynamic and high-stakes regulatory environment. Crypto Is No Longer the Wild West […]
Author: Dan Brecher
New Jersey’s Next Manufacturing Tax Credit: Stability Secured, Timing Matters
A Settled Regulatory Environment Enables Confident Capital Planning New Jersey’s new manufacturing incentive program, Next New Jersey Manufacturing Program, enters 2026 with something uncommon in economic development these days: policy stability. The statute is enacted, New Jersey Economic Development Authority’s (“NJEDA”) rules are adopted, and the application portal is open. With the election outcome settled, […]
Author: Michael J. Sheppeard
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.